BSEMahamaya Lifesciences LtdMinimalNeutral
Announced Wed, 15 Apr · 18:05 IST

Submission of Non-Applicability of the Compliance on Corporate Governance as required under Regulation 27(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹170.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.4+4.7+7.6+15.0+11.1+9.7+11.7+1.0+1.8-3.0
Up moveDown movePending
AI summary

Mahamaya Lifesciences Ltd has informed BSE that it is exempt from filing quarterly/half-yearly/yearly Corporate Governance Reports as required under Regulation 27(2) of SEBI LODR 2015. The company qualifies for this exemption because its equity shares are listed on the BSE SME Platform, which falls under the exemption criteria specified in Regulation 15(2)(b) of SEBI LODR 2015. The filing was signed by Shilpi Bhardwaj, Company Secretary & Compliance Officer, dated April 15, 2026.

Likely market impact

No material impact on shareholders. SME-listed companies are exempt from detailed corporate governance reporting, which is standard practice for smaller listed entities.